All In Biotech

Drug Trial Radar · NCT06559163

A Study of Obexelimab in Patients With Systemic Lupus Erythematosus

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Obexelimab in Patients With Systemic Lupus Erythematosus

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 190 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

190

Actual

Start

Sep 17, 2024

Primary completion

Sep 23, 2026

Study completion Dec 2026

Sponsor

Lead sponsor
Zenas BioPharma (USA), LLCIndustry
Sponsor type
Industry
First posted
Aug 19, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aims to examine the efficacy and safety of obexelimab in participants with systemic lupus erythematosus (SLE).

Conditions

  • Systemic Lupus Erythematosus

Interventions

  • ObexelimabDrug

    Obexelimab is a monoclonal antibody that simultaneously binds CD19 and FcyRllb, resulting in down regulation of B cell activity.

  • PlaceboDrug

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary Outcome MeasureTime frame: 24 weeks

Locations

110 sites in 18 countries. Site status is shown where the registry gives one.

  • Onyx Clinical Research

    Peoria, Arizona

  • Sierra Pacific Arthritis and Rheumatology Centers

    Fresno, California

  • California Research Institute

    Huntington Park, California

  • University of California, San Diego

    La Jolla, California

  • University of California, Los Angeles

    Los Angeles, California

  • Solace Clinical Research

    Tustin, California

  • Yale University

    New Haven, Connecticut

  • Clinical Research of West Florida, Inc

    Clearwater, Florida

  • Clinical Research of West Florida, Inc.

    Tampa, Florida

  • Emory University

    Atlanta, Georgia

  • AARA Clinical Research - Chicago Arthritis & Regenerative Medicine

    Chicago, Illinois

  • Orthoillinois

    Rockford, Illinois

  • Willow Rheumatology and Wellness

    Willowbrook, Illinois

  • Accurate Clinical Research

    Lake Charles, Louisiana

  • Axon Clinical Research

    Baltimore, Maryland

  • UMass Chan Medical School

    Worcester, Massachusetts

  • Henry Ford Hospital

    Detroit, Michigan

  • Juno DO, PC

    Lansing, Michigan

  • Revive Research Institute - Sterling Heights

    Sterling Heights, Michigan

  • Velocity Clinical Research

    St Louis, Missouri

  • Hospital for Special Surgery

    New York, New York

  • SUNY Upstate Medical University

    Syracuse, New York

  • DJL Clinical Research PLLC

    Charlotte, North Carolina

  • Cross Creek Medical Clinic

    Fayetteville, North Carolina

  • Onsite Clinical Solutions

    Salisbury, North Carolina

  • Oklahoma Medical Research Foundation

    Oklahoma City, Oklahoma

  • Penn State - Hershey Medical Center

    Hershey, Pennsylvania

  • AARA Clinical Research - Rheumatology Specialty Center

    Willow Grove, Pennsylvania

  • Prolato Clinical Research Center (PCRC)

    Houston, Texas

  • Accurate Clinical Research

    Houston, Texas

  • Prime Clinical Research - Lewisville

    Lewisville, Texas

  • Prime Clinical Research - Mansfield

    Mansfield, Texas

  • UZ Leuven

    Leuven, Belgium

  • CHU de Liege

    Liège, Belgium

  • Medical Center Medtech Services EOOD

    Haskovo, Bulgaria

  • University Multiprofile Hospital for Active Treatment "Eurohospital Plovdiv"

    Plovdiv, Bulgaria

  • Diagnostic Consultative Center Convex EOOD

    Sofia, Bulgaria

  • Richmond Clinical Trials

    Richmond, British Columbia, Canada

  • Riverside Professional Centre

    Sydney, Nova Scotia, Canada

  • The Second Affiliated Hospital of Soochow University

    Suzhou, China

Showing 40 of 110 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.